Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imipramine and rheumatoid factor

A L MacNeill, W C Dick

    The Journal of International Medical Research
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated imipramine for rheumatoid arthritis. The antidepressant imipramine (75 mg) did not significantly alter rheumatoid factor levels in patients with rheumatoid arthritis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The clinical significance of indomethacin-probenecid interaction.

    British journal of clinical pharmacology·2012
    Same author

    The effect of frusemide on indomethacin plasma levels.

    British journal of clinical pharmacology·2012
    Same author

    Myxoma virus induces apoptosis in cultured feline carcinoma cells.

    Research in veterinary science·2011
    Same author

    Effects of ophthalmic disease on concentrations of plasma fibrinogen and serum amyloid A in the horse.

    Equine veterinary journal·2011
    Same author

    Fatal subaxial dislocation of cervical spine in rheumatoid arthritis.

    British medical journal·2010
    Same author

    The role of the cowpox virus crmA gene during intratracheal and intradermal infection of C57BL/6 mice.

    Virology·2008
    Same journal

    Platelet-to-albumin ratio and postoperative bleeding after endovascular treatment of intracranial aneurysms: A retrospective cohort study.

    The Journal of international medical research·2026
    Same journal

    Determinants of cleft lip and cleft palate in Ethiopian children: Insights from a hospital-based study using Bayesian modeling.

    The Journal of international medical research·2026
    Same journal

    Etiology, surgical management, and outcomes of patients with scleral thinning.

    The Journal of international medical research·2026
    Same journal

    Hemichorea associated with nonketotic hyperglycemia: A case report with unremarkable neuroimaging at presentation.

    The Journal of international medical research·2026
    Same journal

    Diagnostic performance of machine learning-based radiomics models for predicting epidermal growth factor receptor mutation status in lung adenocarcinoma in Chinese patients: A systematic review and meta-analysis.

    The Journal of international medical research·2026
    Same journal

    Postlumbar puncture spinal intradural hematoma: A case report and literature review.

    The Journal of international medical research·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Psychopharmacology

    Background:

    • Rheumatoid arthritis is an autoimmune disease characterized by joint inflammation and the presence of rheumatoid factor.
    • Previous reports suggested imipramine may reduce rheumatoid factor titers in schizophrenic patients, prompting further investigation.

    Purpose of the Study:

    • To evaluate the efficacy of imipramine in reducing rheumatoid factor (RF) levels in patients with rheumatoid arthritis.
    • To determine if imipramine, at a dose of 75 mg, impacts RF titers in a double-blind, placebo-controlled setting.

    Main Methods:

    • A double-blind, placebo-controlled trial was conducted.
    • Twenty outpatients with classical rheumatoid arthritis and RF titre >= 1:64 were enrolled.
    • Participants received either imipramine 75 mg or a matching placebo.

    Related Experiment Videos

    Main Results:

    • Imipramine treatment at 75 mg did not significantly affect rheumatoid factor levels.
    • No statistically significant difference in RF titre was observed between the imipramine and placebo groups.

    Conclusions:

    • The studied dose of imipramine (75 mg) is ineffective in reducing rheumatoid factor levels in patients with rheumatoid arthritis.
    • Further research may be needed to explore other dosages or therapeutic strategies for managing rheumatoid factor in this patient population.